EVALUATION OF NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY INVIVO IN PATIENTS TREATED WITH HIGH-DOSE INTERLEUKIN-2 AND ADOPTIVE TRANSFER OF AUTOLOGOUS LAK CELLS

被引：17
|
作者：
WALEWSKI, J
PAIETTA, E
DUTCHER, J
WIERNIK, PH
机构：
[1] MONTEFIORE MED CTR,DEPT ONCOL,111 E 210TH ST,BRONX,NY 10467
[2] ALBERT EINSTEIN MED CTR,DEPT MED,BRONX,NY 10467
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1989年 / 115卷 / 02期
关键词：
D O I：
10.1007/BF00397919
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 174
页数：5
相关论文
共 50 条
  • [31] TREATMENT OF RECURRENT GLIOBLASTOMA WITH LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2)
    YOUNG, HF
    MERCHANT, LH
    COOK, SHS
    MERCHANT, RE
    NEUROSURGERY, 1988, 23 (02) : 261 - 261
  • [32] INTERLEUKIN-7 (IL-7) INDUCES LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY AGAINST ALLOGENEIC AND AUTOLOGOUS MELANOMA-CELLS
    BOHM, M
    MOLLER, P
    KALBFLEISCH, U
    CZARNEZTKI, BM
    SCHADENDORF, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 590 - 590
  • [33] NATURAL-KILLER (NK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) ACTIVATED KILLER (LAK) CELLS IN CANCER-PATIENTS
    CHING, N
    KUBOTA, I
    LOPEZ, M
    ANCHETA, A
    WONG, GK
    CHING, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 380 - 380
  • [34] PURIFICATION AND CHARACTERIZATION OF HUMAN NATURAL-KILLER (NK) AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS THROUGH THE STAINING OF THEIR CONTENT OF LYSOSOMES
    SHAU, H
    GRAY, JD
    MITCHELL, MS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 352 - 352
  • [35] LYSIS OF AUTOLOGOUS MONOCYTES BY LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FROM CANCER-PATIENTS
    BLANCHARD, DK
    SERBOURSEK, D
    LYMAN, GH
    KAVANAGH, JJ
    NICOLETTO, JP
    DJEU, JY
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 396 - 396
  • [36] INTERLEUKIN-7 (IL-7) INDUCES LYMPHOKINE-ACTIVATED KILLER (LAK) CELL-ACTIVITY AGAINST ALLOGENEIC AND AUTOLOGOUS MELANOMA-CELLS
    BOHM, M
    MOLLER, P
    KALBFLEISCH, U
    CZARNEZTKI, BM
    SCHADENDORF, D
    CLINICAL RESEARCH, 1993, 41 (02): : A489 - A489
  • [37] TRANSCATHETER ARTERIAL INJECTION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS INTO PATIENTS WITH LIVER CANCERS
    KOMATSU, T
    YAMAUCHI, K
    FURUKAWA, T
    OBATA, H
    JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (03) : 167 - 174
  • [38] INVIVO BOOSTING OF LUNG NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY INTERLEUKIN-2 - COMPARISON OF SYSTEMIC, INTRAPLEURAL AND INHALATION ROUTES
    FLEXMAN, JP
    MANNING, LS
    ROBINSON, BWS
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 82 (01): : 151 - 156
  • [39] ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) FOR RECURRENT GLIOBLASTOMA
    MERCHANT, RE
    MERCHANT, LH
    YOUNG, HF
    JOURNAL OF NEURO-ONCOLOGY, 1987, 5 (02) : 177 - 177
  • [40] LYMPHOKINE-ACTIVATED AND NATURAL-KILLER CELL-ACTIVITY IN HUMAN INTESTINAL-MUCOSA
    HOGAN, PG
    HAPEL, AJ
    DOE, WF
    JOURNAL OF IMMUNOLOGY, 1985, 135 (03): : 1731 - 1738
12345